These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8381011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF, Young GA, Khazan N.
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract] [Full Text] [Related]

  • 24. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR, France CP.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [Abstract] [Full Text] [Related]

  • 25. Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys.
    Stevenson GW, Wentland MP, Bidlack JM, Mello NK, Negus SS.
    Eur J Pharmacol; 2004 Dec 15; 506(2):133-41. PubMed ID: 15588733
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
    Preston KL, Bigelow GE, Liebson IA.
    Pharmacol Biochem Behav; 1990 Nov 15; 37(3):511-22. PubMed ID: 1708145
    [Abstract] [Full Text] [Related]

  • 28. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul 15; 254(1):245-52. PubMed ID: 2164093
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A, Morse WH, Bergman J.
    J Pharmacol Exp Ther; 1996 Apr 15; 277(1):462-72. PubMed ID: 8613955
    [Abstract] [Full Text] [Related]

  • 34. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
    Negus SS, Gatch MB, Mello NK, Zhang X, Rice K.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):362-75. PubMed ID: 9655881
    [Abstract] [Full Text] [Related]

  • 35. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL, McMahon LR, France CP.
    J Pharmacol Exp Ther; 2003 Sep 15; 306(3):1167-73. PubMed ID: 12766254
    [Abstract] [Full Text] [Related]

  • 36. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
    Mello NK, Fivel PA, Kohut SJ, Carroll FI.
    Neuropsychopharmacology; 2014 Apr 15; 39(5):1222-31. PubMed ID: 24304823
    [Abstract] [Full Text] [Related]

  • 37. Nalbuphine.
    Schmidt WK, Tam SW, Shotzberger GS, Smith DH, Clark R, Vernier VG.
    Drug Alcohol Depend; 1985 Feb 15; 14(3-4):339-62. PubMed ID: 2986929
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats.
    Liles JH, Flecknell PA.
    Lab Anim; 1992 Jul 15; 26(3):180-9. PubMed ID: 1501431
    [Abstract] [Full Text] [Related]

  • 40. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys.
    Paronis CA, Gasior M, Bergman J.
    Psychopharmacology (Berl); 2002 Oct 15; 163(3-4):283-91. PubMed ID: 12373429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.